blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2266960

EP2266960 - Aryl-substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles as anticonvulsants [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.11.2014
Database last updated on 15.06.2024
Most recent event   Tooltip17.06.2016Lapse of the patent in a contracting state
New state(s): IT		published on 20.07.2016  [2016/29]
Applicant(s)For all designated states
EURO-CELTIQUE S.A.
2, avenue Charles de Gaulle
1653 Luxembourg / LU
[2010/52]
Inventor(s)01 / Hogenkamp, Derk J
4510 Park Drive
Carlsbad CA 92008 / US
02 / Upasani, Ravindra
63 Montecilo
Fothill Ranch CA 92610 / US
03 / Nguyen, Phong
1048 Wingfood Street
Placentia CA 92870 / US
 [2010/52]
Representative(s)Harris, Jennifer Lucy, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2010/52]Harris, Jennifer Lucy, et al
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date10004963.424.03.2000
[2010/52]
Priority number, dateUS19990126553P26.03.1999         Original published format: US 126553 P
[2010/52]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2266960
Date:29.12.2010
Language:EN
[2010/52]
Type: A3 Search report 
No.:EP2266960
Date:09.11.2011
Language:EN
[2011/45]
Type: B1 Patent specification 
No.:EP2266960
Date:22.01.2014
Language:EN
[2014/04]
Search report(s)(Supplementary) European search report - dispatched on:EP10.10.2011
ClassificationIPC:C07D207/30, C07D233/54, A61K31/40, A61K31/415, A61K31/421, A61K31/426, A61K31/496, A61K31/506, A61K31/4164, A61K31/5377, C07D235/18, C07D277/56, C07D231/12, C07D233/64, C07D403/04, C07D207/416, C07D263/34
[2011/45]
CPC:
C07D207/416 (EP,KR,US); A61P21/02 (EP); A61P23/02 (EP);
A61P25/00 (EP); A61P25/04 (EP); A61P25/06 (EP);
A61P25/08 (EP); A61P25/16 (EP); A61P25/18 (EP);
A61P25/22 (EP); A61P25/24 (EP); A61P25/28 (EP);
A61P27/06 (EP); A61P27/16 (EP); A61P29/00 (EP);
A61P43/00 (EP); A61P9/06 (EP); A61P9/10 (EP);
C07D231/12 (EP,KR,US); C07D233/54 (EP,KR,US); C07D233/64 (EP,KR,US);
C07D235/18 (EP,KR,US); C07D263/34 (EP,KR,US); C07D277/56 (EP,KR,US);
C07D403/04 (EP,KR,US) (-)
Former IPC [2010/52]C07D231/10, C07D207/30, C07D233/54, A61K31/40, A61K31/415, A61K31/421, A61K31/426, A61K31/496, A61K31/506, A61K31/4164, A61K31/5377, A61P25/00
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2010/52]
TitleGerman:Arylsubstituierte Pyrazole, Imidazole, Oxazole,Thiazole und Pyrrole als Antikonvulsiva[2010/52]
English:Aryl-substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles as anticonvulsants[2010/52]
French:Pyrazoles, imidazoles, oxazoles, thiazoles et pyrroles, substitués d'aryl à titre d'anticonvulsants[2010/52]
Examination procedure09.05.2012Amendment by applicant (claims and/or description)
09.05.2012Examination requested  [2012/25]
24.08.2012Despatch of a communication from the examining division (Time limit: M04)
24.12.2012Reply to a communication from the examining division
14.08.2013Communication of intention to grant the patent
28.11.2013Fee for grant paid
28.11.2013Fee for publishing/printing paid
Parent application(s)   TooltipEP00919636.1  / EP1173169
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20000919636) is  16.08.2007
Opposition(s)23.10.2014No opposition filed within time limit [2015/01]
Fees paidRenewal fee
10.09.2010Renewal fee patent year 03
10.09.2010Renewal fee patent year 04
10.09.2010Renewal fee patent year 05
10.09.2010Renewal fee patent year 06
10.09.2010Renewal fee patent year 07
10.09.2010Renewal fee patent year 08
10.09.2010Renewal fee patent year 09
10.09.2010Renewal fee patent year 10
10.09.2010Renewal fee patent year 11
10.03.2011Renewal fee patent year 12
07.03.2012Renewal fee patent year 13
08.03.2013Renewal fee patent year 14
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT22.01.2014
BE22.01.2014
CY22.01.2014
DK22.01.2014
ES22.01.2014
FI22.01.2014
IT22.01.2014
MC22.01.2014
NL22.01.2014
SE22.01.2014
IE24.03.2014
LU24.03.2014
CH31.03.2014
LI31.03.2014
GR23.04.2014
PT22.05.2014
[2016/29]
Former [2016/28]AT22.01.2014
BE22.01.2014
CY22.01.2014
DK22.01.2014
ES22.01.2014
FI22.01.2014
MC22.01.2014
NL22.01.2014
SE22.01.2014
IE24.03.2014
LU24.03.2014
CH31.03.2014
LI31.03.2014
GR23.04.2014
PT22.05.2014
Former [2016/27]AT22.01.2014
BE22.01.2014
CY22.01.2014
DK22.01.2014
ES22.01.2014
FI22.01.2014
MC22.01.2014
NL22.01.2014
SE22.01.2014
IE24.03.2014
LU24.03.2014
CH31.03.2014
LI31.03.2014
PT22.05.2014
Former [2015/08]AT22.01.2014
BE22.01.2014
CY22.01.2014
DK22.01.2014
ES22.01.2014
FI22.01.2014
NL22.01.2014
SE22.01.2014
IE24.03.2014
LU24.03.2014
CH31.03.2014
LI31.03.2014
PT22.05.2014
Former [2015/07]AT22.01.2014
BE22.01.2014
CY22.01.2014
DK22.01.2014
ES22.01.2014
FI22.01.2014
NL22.01.2014
SE22.01.2014
IE24.03.2014
LU24.03.2014
PT22.05.2014
Former [2014/48]AT22.01.2014
BE22.01.2014
CY22.01.2014
DK22.01.2014
ES22.01.2014
FI22.01.2014
NL22.01.2014
SE22.01.2014
LU24.03.2014
PT22.05.2014
Former [2014/41]AT22.01.2014
BE22.01.2014
CY22.01.2014
ES22.01.2014
FI22.01.2014
NL22.01.2014
SE22.01.2014
PT22.05.2014
Former [2014/39]AT22.01.2014
CY22.01.2014
ES22.01.2014
FI22.01.2014
NL22.01.2014
SE22.01.2014
PT22.05.2014
Former [2014/37]AT22.01.2014
CY22.01.2014
ES22.01.2014
FI22.01.2014
SE22.01.2014
PT22.05.2014
Documents cited:Search[X]EP0192998  (BASF AG [DE]) [X] 1,6,8 * compounds 5,48-50 *;
 [X]EP0269238  (MAY & BAKER LTD [GB]) [X] 1,6 * p. 19, lines 35 and 58 *;
 [XD]JPH0725849  (NIPPON SODA CO) [XD] 1,6 * p. 5, table 1, cpd. 9 *;
 [A]EP0640593  (HOECHST AG [DE]) [A] 1-15* examples and page 8, lines 15-23 *;
 [X]WO9840364  (SEARLE & CO [US], et al) [X] 1,6,8 * Ex. 1, cpd (c) Ex. 4 Ex. 17, cpds. (c) and (d) *;
 [X]  - H. SCHUBERT ET AL., "p-Aryl- und p-Alkoxyphenyl-imidazole", JOURNAL FUER PRAKTISCHE CHEMIE, (1962), vol. 18, no. 3-4, pages 192 - 202, XP002659431 [X] 1,6 * p. 199, 2nd cpd. p. 200, 1st cpd. *
 [X]  - ROBERTSON D W ET AL, "STRUCTURE-ACTIVITY RELATIONSHIPS OF ARYLIMIDAZOPYRIDINE CARDIOTONICS: DISCOVERY AND INOTROPIC ACTIVITY OF 2-Ú2-METHOXY-4- (METHYLSULFINYL)PHENYL 3/4 -1 H-IMIDAZOÚ4,5-C 3/4 PYRIDINE", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (19850601), vol. 28, no. 6, doi:10.1021/JM00383A006, ISSN 0022-2623, pages 717 - 727, XP000577047 [X] 1,6 * p. 722, table II (cpds. 32, 55) *

DOI:   http://dx.doi.org/10.1021/jm00383a006
 [X]  - YAMADA NAOTAKA ET AL, "Synthesis and bleaching activity of 1,5-disubstituted imidazoles", BIOSCIENCE BIOTECHNOLOGY BIOCHEMISTRY, JAPAN SOCIETY FOR BIOSCIENCE, BIOTECHNOLOGY, AND AGROCHEMISTRY, TOKYO, JAPAN, (19920101), vol. 56, no. 12, doi:10.1271/BBB.56.1943, ISSN 0916-8451, pages 1943 - 1948, XP002613769 [X] 1,6 * p. 1944, table I, cpd. 21 *

DOI:   http://dx.doi.org/10.1271/bbb.56.1943
 [X]  - TROFIMOV ET AL., "Pyrroles from ketoximes and acetylene", CHEMISTRY OF HETEROCYCLIC COMPOUNDS, (1978), vol. 14, pages 399 - 401, XP002659432 [X] 1,6 * Cpd. VIII *
 [X]  - HILBORN J G ET AL, "POLY(ARYL ETHER-BENZOXAZOLES)", MACROMOLECULES, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC; US, (19900528), vol. 23, no. 11, doi:10.1021/MA00213A006, ISSN 0024-9297, pages 2854 - 2861, XP000175126 [X] 1,6,8 * page 2857; compound 2 *

DOI:   http://dx.doi.org/10.1021/ma00213a006
 [X]  - YAKOBIVICH V S ET AL, "Polybenzoxazoles. Synthesis and properties of polymers containing oxygen and sulphur atoms in the chain", POLYMER SCIENCE U.S.S.R, PERGAMON, vol. 9, no. 9, doi:10.1016/0032-3950(67)90023-8, ISSN 0032-3950, (19670101), pages 2227 - 2242, (19670101), XP024126680 [X] 1,6,8 * p. 2240, 7-9 p. 2240, 12-13 *

DOI:   http://dx.doi.org/10.1016/0032-3950(67)90023-8
 [X]  - HEDRICK J L, "IMIDE-ARYL ETHER BENZOTHIAZOLES", POLYMER, ELSEVIER SCIENCE PUBLISHERS B.V, GB, (19920101), vol. 33, no. 7, doi:10.1016/0032-3861(92)90113-B, ISSN 0032-3861, pages 1399 - 1405, XP002930513 [X] 1,6,8 * page 1402; compound 2 *

DOI:   http://dx.doi.org/10.1016/0032-3861(92)90113-B
 [X]  - RADWAN S M, "SYNTHESIS AND REACTIONS OF SOME DIPHENYL SULFIDES", COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, INSTITUTE OF ORGANIC CHEMISTRY & BIOCHEMISTRY, PRAGUE; CZ, (19920101), vol. 57, doi:10.1135/CCCC19921553, ISSN 0010-0765, pages 1553 - 1558, XP002930514 [X] 1,6 * compounds Xa, Xc *

DOI:   http://dx.doi.org/10.1135/cccc19921553
 [X]  - KAWAMATSU Y ET AL, "2-Amino-4-phenylthiazole derivatives as anit-atherogenic agents", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, EDITIONS SCIENTIFIQUE ELSEVIER, PARIS, FR, (19810101), vol. 16, no. 4, ISSN 0223-5234, pages 355 - 362, XP002254107 [X] 1,6 * p. 356, table I; entries 5, 6 *
by applicantJPS5975257
 EP0269238
 EP0446180
 JPH05287563
 WO9323374
 JPH0725849
 WO9640628
 US5741818
 JPH10168063
 WO9850348
 WO9852940
 WO9911627
    - CATTERALL, W.A., TRENDS PHARMACOL. SCI., (1987), vol. 8, pages 57 - 65
    - GRAHAM ET AL., J PHARMACOL. EXP. THER., (1994), vol. 269, pages 854 - 859
    - BROWN ET AL., BRITISH J. PHARMACOL., (1995), vol. 115, pages 1425 - 1432
    - STYS, J NEUROSCI., (1992), vol. 12, pages 430 - 439
    - BENSIM ET AL., NEW ENGL. J. MED, (1994), vol. 330, pages 585 - 591
    - TAYLOR; MELDRUM, TRENDS PHARMACOL. SCI., (1995), vol. 16, pages 309 - 316
    - DENICOTT ET AL., J. CLIN. PSYCHIATRY, (1994), vol. 55, pages 70 - 76
    - MOLLER, A. R, AM. J. OTOL., (1997), vol. 18, pages 577 - 585
    - TONNDORF, J, HEAR. RES., (1987), vol. 28, pages 271 - 275
    - SIMPSON, J. J.; DAVIES, E. W., TIP., (1999), vol. 20, pages 12 - 18
    - MAJUMDAR, B., CLIN. OROLARYNGOL., (1983), vol. 8, pages 175 - 180
    - DONALDSON, I., LAQYNGOL. OTOL., (1981), vol. 95, pages 947 - 951
    - CATTERALL, W.A, SCIENCE, (1988), vol. 2-2, pages 50 - 61
    - CATTERALL, W.A., ANN. REV. PHARMACOL. TOXICOL., (1980), vol. 10, pages 15 - 43
    - DIMMOCK ET AL., J MED CHEM., (1996), vol. 39, pages 3984 - 3997
    - PEVARELLO ET AL., J. MED CHEM., (1998), vol. 41, pages 579 - 590
    - RADWAN, S. M., COLLECT CZECH CHEM. COMMUN., (1992), vol. 57, no. 7, pages 1553 - 1558
    - KORSHAK, K. K. ET AL., POLYM. SCI. USSR (ENGL. TRANSL.), (1964), vol. 6, no. 1087, pages 1196 - 1198
    - J. POLYM. SCI. PART A, (1965), vol. 3, pages 2425 - 2439
    - STILLE ET AL., J POLYM. SCI. PART A-1, (1968), vol. 6, pages 2317 - 2330
    - SZMANT ET AL., J. AM. CHEM. SOC., (1956), vol. 78, pages 4386 - 4389
    - GRANDBERG ET AL., J. GEN. CHEM. USSR (ENGL. TRANSL), (1960), vol. 30, pages 1404 - 1408
    - YAMADA ET AL., BIOSCI. BIOTECHNOL. BIOCHEM., (1992), vol. 56, pages 1943 - 1948
    - KUWANO ET AL., AGRIC. BIOL. CHEM, (1991), vol. 55, pages 2999 - 3004
    - WALKER ET AL., J. CHEM. SOC., (1942), pages 347 - 350
    - SCHUBERT ET AL., J PRAKT. CHEM., (1962), vol. 18, no. 3-4, pages 192 - 202
    - TODOROVA ET AL., TR. NAUCHNOIZSLED. KHIM.-FARM. INST., (1978), vol. 10, pages 85 - 94
    - VODENICHAROV ET AL., DOKL. BOLG. AKAD NAUK., (1978), vol. 31, no. 4, pages 441 - 444
    - GOLANOVA ET AL., ZH. ORG. KHIM., (1993), vol. 29, pages 1319 - 1324
    - ERMIKOW ET AL., Z. OBSHCH. KHIM., (1988), vol. 58, pages 450 - 457
    - TROFIMOV ET AL., KHIM. GETEROTSIKL. SOEDIN., (1978), vol. 4, pages 489 - 491
    - KOROSTOVA ET AL., KHIM. GETERORSIKL. SOEDIN., (1992), vol. 5, pages 609 - 613
    - ANDERSON ET AL., J. MED CHEM., (1979), vol. 22, pages 977 - 980
    - DANN ET AL., LIEBIGS ANN. CHEM., (1984), vol. 3, pages 409 - 425
    - PICHON. M ET AL., TERRAHEDRON LETT., (1966), vol. 37, pages 7963 - 7966
    - FOURNIE-ZALUSKI, M-C. ET AL., J. MED CHEM., (1996), vol. 39, pages 2594 - 2608
    - VERDOOM, T.A. ET AL., NEURON, (1990), vol. 4, pages 919 - 928
    - HAMILL ET AL., PFLUEGERS ARCH., (1981), vol. 391, pages 85 - 100
    - VERDOOM, T.A ET AL., NEURON, (1990), vol. 4, pages 919 - 928
    - YASUSHI, J. BIOL. CHEM., (1986), vol. 261, pages 6149 - 6152
    - CREVELING, MOL. PHARMACAL., (1983), vol. 23, pages 350 - 358
    - HUNSKAAR, S.; O. B. FASMER; K. HOLE. J., NEUROSCI. METHODS, (1985), vol. 14, pages 69 - 76
    - BUCHAN ET AL., STROKE, (1993), pages 148 - 152
    - SHEARDOWN ET AL., EUR. J. PHARMACOL., (1993), vol. 236, pages 347 - 353
    - GRAHAM, J PHARMACAL. EXP. THERAP., (1996), vol. 276, pages 1 - 4
    - WRATHALL, EXP. NEUROLOGY, (1996), vol. 137, pages 119 - 126
    - IWASAKI, J NEURO SCI., (1995), vol. 134, pages 21 - 25
    - RAGSDALE ET AL., MOL. PHARMACOL., (1991), vol. 40, pages 756 - 765
    - KUO; BEAN, MOL. PHARMACOL., (1994), vol. 46, pages 716 - 725
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.